Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer

Clinical trial NCT03231176 · COMPLETED

Trial details

NCT number: NCT03231176
Sponsor: ASLAN Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2017-12-19
Primary completion: 2019-07-05
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.